EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Unravelling the Gut–Microbiome–Brain Axis: Implications for Infant Neurodevelopment and Future Therapeutics

Absar Talat, Azna Zuberi, Asad U Khan

Current Microbiology · 2025

DOI: 10.1007/s00284-025-04370-3 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Microbiology, 2025. Verfasst von Absar Talat und 2 weiteren Autor:innen. Beteiligte Einrichtung: Antimicrobial Resistance Lab, Interdisciplinary Biotechnology Unit, Aligarh Muslim University, Aligarh, 202002, India. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Brain, Neurodevelopmental Disorders. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 152 Literaturangaben. Gefördert von: Department of Biotechnology, Ministry of Science and Technology, India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The microbiome-gut-brain axis signifies the intricate interplay between gut microbiome and brain, facilitated by bidirectional communication channels. The brain modulates gut function through the hypothalamic-pituitary-adrenal axis and the autonomic nervous system, while the gut influences central nervous system (CNS) function through microbial metabolites, neurotransmitters, and gut hormones. Early brain development in infants is shaped by mother to neonate microbiome transmission, mode of birth, gestational length, breastfeeding, maternal and infant antibiotic exposure, and acquired infections. Dysbiosis in the gut microbiome is associated with various neurodevelopmental disorders in children such as attention-deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). In this review, we elucidate the pivotal role of the microbiome-gut brain axis in a child's neural development, exploring factors modulating this intricate interaction. Furthermore, we discuss the potential future therapeutic avenues that can support optimal neurodevelopment, such as probiotics, prebiotics, synbiotics, postbiotics, CRISPR/Cas9, fecal microbiota transplant, and phage therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeBrainNeurodevelopmental DisordersHumansInfantDysbiosisProbioticsInfant, NewbornAnimals

Autor:innen und Institutionen

  • Antimicrobial Resistance Lab, Interdisciplinary Biotechnology Unit, Aligarh Muslim University, Aligarh, 202002, India.
  • Bioinformatics and Computational Biology Centre of DBT Government of India, Interdisciplinary Biotechnology Unit, Aligarh Muslim University, Aligarh, 202002, India.
  • Division of Reproductive Science in Medicine, Department of Obstetrics and Gynaecology, Feinberg School of Medicine, Northwestern University, Chicago, IL, 60610, USA.
  • Antimicrobial Resistance Lab, Interdisciplinary Biotechnology Unit, Aligarh Muslim University, Aligarh, 202002, India. asad.k@rediffmail.com.
  • Bioinformatics and Computational Biology Centre of DBT Government of India, Interdisciplinary Biotechnology Unit, Aligarh Muslim University, Aligarh, 202002, India. asad.k@rediffmail.com.

Förderung

  • Department of Biotechnology, Ministry of Science and Technology, India

Zitieren

APA

Talat, A., Zuberi, A., & Khan, A. U. (2025). Unravelling the Gut–Microbiome–Brain Axis: Implications for Infant Neurodevelopment and Future Therapeutics. Current Microbiology. https://doi.org/10.1007/s00284-025-04370-3

Vancouver

Talat A, Zuberi A, Khan AU. Unravelling the Gut–Microbiome–Brain Axis: Implications for Infant Neurodevelopment and Future Therapeutics. Current Microbiology. 2025. doi:10.1007/s00284-025-04370-3

BibTeX
@article{Talat2025,
  author = {Talat, Absar and Zuberi, Azna and Khan, Asad U},
  title = {Unravelling the Gut–Microbiome–Brain Axis: Implications for Infant Neurodevelopment and Future Therapeutics},
  journal = {Current Microbiology},
  year = {2025},
  doi = {10.1007/s00284-025-04370-3}
}
Kostenlos starten →